Akorn gets U.S. approval to buy Hi-Tech Pharmacal, with conditions

[Reuters] – Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, … more

View todays social media effects on AKRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Akorn is hiring next, click here to view